F-Prime Capital

Investor type

VC

Founded

1969

AUM

$4 500 M

Location

Cambridge, Massachusetts, United States

Investment Ticket

$0-1 m

Investment Stage

Series A Seed Series B Late Stage (Series C+)

Region of investment

Europe North America Asia
Investor profile last updated: 16 August, 2026

Profile

F-Prime Capital is a venture capital firm based in the United States. They have built a seasoned team consisting of scientists, engineers, physicians, operators, and investors, who together bring a wealth of real-world expertise to the companies they invest in. The firm focuses on accelerating the growth of their portfolio companies, driven by a shared vision of innovation and impact.

F-Prime Capital invests in a variety of sectors including life sciences, technology, healthtech and services, and crypto. They target companies at various stages of development, providing support to businesses from concept to growth. The firm holds a robust portfolio with investments in numerous breakthrough companies within their stated sectors.

Some notable portfolio companies under F-Prime Capital include Innovent Biologics - a Chinese biopharmaceutical firm, Iora Health - a network for primary care, AviadioBio - a gene therapy company, Lighthouse - a technology-enabled personalized learning services, and PatientPing - a provider of real-time patient data for healthcare providers. These investments reflect F-Prime Capital's commitment to fostering innovation across different sectors.

Industry

Business Services (B2B) Education Edtech Fashion/Beauty Financial Services Fintech Food and Beverage TravelTech Foodtech Gaming Healthcare Services Industrial IT Services Medical Devices Pharmaceuticals SaaS Security Software Blockchain/Crypto AI MedTech Technology Life Sciences HealthTech Biotechnology

F-Prime Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
F-Prime Capital Partners Life Sciences Fund VI LP
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
AI
HealthTech
Pre-seed
Seed
North America
Europe
Asia
$5-10 m
June 2012

Contacts

Name
Title
Email
avatar
Jillian Enos Vice President, Finance
Vice President, Finance
j•••@•••
avatar
Gaurav Tuli Partner
Partner
g•••@•••
Upgrade to see contacts
avatar
DA3zVZGUF2ChYlwE DA3zVZGUF2ChYlwE
DA3zVZGUF2ChYlwE
avatar
DA3zVZGUF2ChYlwE DA3zVZGUF2ChYlwE
DA3zVZGUF2ChYlwE
avatar
DA3zVZGUF2ChYlwE DA3zVZGUF2ChYlwE
DA3zVZGUF2ChYlwE
Investment-team contacts for F-Prime Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about F-Prime Capital

F-Prime Capital is a venture capital firm. It backs companies at Series A, Seed, Series B and Late Stage (Series C+), writing tickets of $0-1 m.
F-Prime Capital is located in Cambridge, Massachusetts, United States.
F-Prime Capital was founded in 1969.
F-Prime Capital invests in companies and startups in Business Services (B2B), Education, Edtech, Fashion/Beauty, Financial Services, Fintech, Food and Beverage, TravelTech, Foodtech, Gaming, Healthcare Services, Industrial, IT Services, Medical Devices, Pharmaceuticals, SaaS, Security, Software, Blockchain/Crypto, AI, MedTech, Technology, Life Sciences, HealthTech, Biotechnology.
F-Prime Capital invests in companies and startups in Europe, North America, Asia.
F-Prime Capital invests in companies and startups at Series A, Seed, Series B, Late Stage (Series C+).
F-Prime Capital usually invests $0-1 m on average.
F-Prime Capital has around $4 500m assets under management.
F-Prime Capital last fund was created/launched in 2012-06-06
F-Prime Capital can be reached through its website fprimecapital.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for F-Prime Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query F-Prime Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.